Annual CFO
-$144.03 M
+$249.24 M+63.38%
December 31, 2024
Summary
- As of March 14, 2025, LEGN annual cash flow from operations is -$144.03 million, with the most recent change of +$249.24 million (+63.38%) on December 31, 2024.
- During the last 3 years, LEGN annual CFO has risen by +$54.43 million (+27.43%).
- LEGN annual CFO is now -146.81% below its all-time high of $307.68 million, reached on December 31, 2018.
Performance
LEGN Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
N/A
December 31, 2024
Summary
- LEGN quarterly cash flow from operations is not available.
Performance
LEGN Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM CFO
N/A
December 31, 2024
Summary
- LEGN TTM cash flow from operations is not available.
Performance
LEGN TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
LEGN Cash From Operations Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +63.4% | - | - |
3 y3 years | +27.4% | - | - |
5 y5 years | -73.4% | - | - |
LEGN Cash From Operations Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +63.4% | ||||
5 y | 5-year | -73.4% | +63.4% | ||||
alltime | all time | -146.8% | +63.4% |
Legend Biotech Cash From Operations History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2024 | -$144.03 M(-63.4%) | - | - |
Sep 2024 | - | -$75.82 M(+4492.5%) | -$157.60 M(+10.5%) |
Jun 2024 | - | -$1.65 M(-110.6%) | -$142.63 M(-40.2%) |
Mar 2024 | - | $15.52 M(-116.2%) | -$238.54 M(-39.3%) |
Dec 2023 | -$393.28 M(+95.4%) | -$95.64 M(+57.2%) | -$393.28 M(+13.2%) |
Sep 2023 | - | -$60.85 M(-37.6%) | -$347.37 M(-3.1%) |
Jun 2023 | - | -$97.57 M(-29.9%) | -$358.64 M(+37.0%) |
Mar 2023 | - | -$139.22 M(+179.9%) | -$261.81 M(+30.1%) |
Dec 2022 | -$201.28 M(+1.4%) | -$49.74 M(-31.0%) | -$201.28 M(-9.0%) |
Sep 2022 | - | -$72.11 M(+9644.9%) | -$221.09 M(+14.2%) |
Jun 2022 | - | -$740.00 K(-99.1%) | -$193.57 M(-22.7%) |
Mar 2022 | - | -$78.69 M(+13.1%) | -$250.37 M(+26.2%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2021 | -$198.47 M(-11.0%) | -$69.55 M(+56.0%) | -$198.47 M(+7.4%) |
Sep 2021 | - | -$44.59 M(-22.5%) | -$184.87 M(-9.7%) |
Jun 2021 | - | -$57.54 M(+114.8%) | -$204.65 M(+0.3%) |
Mar 2021 | - | -$26.79 M(-52.1%) | -$204.00 M(-8.5%) |
Dec 2020 | -$223.00 M(+168.5%) | -$55.95 M(-13.1%) | -$223.00 M(-1.8%) |
Sep 2020 | - | -$64.37 M(+13.2%) | -$227.04 M(+59.1%) |
Jun 2020 | - | -$56.88 M(+24.2%) | -$142.72 M(+14.5%) |
Mar 2020 | - | -$45.80 M(-23.7%) | -$124.60 M(+50.0%) |
Dec 2019 | -$83.06 M(-127.0%) | -$59.99 M(-400.7%) | -$83.06 M(+259.9%) |
Sep 2019 | - | $19.95 M(-151.5%) | -$23.08 M(-46.4%) |
Jun 2019 | - | -$38.77 M(+810.2%) | -$43.02 M(+910.2%) |
Mar 2019 | - | -$4.26 M | -$4.26 M |
Dec 2018 | $307.68 M | - | - |
FAQ
- What is Legend Biotech annual cash flow from operations?
- What is the all time high annual CFO for Legend Biotech?
- What is Legend Biotech annual CFO year-on-year change?
- What is the all time high quarterly CFO for Legend Biotech?
- What is the all time high TTM CFO for Legend Biotech?
What is Legend Biotech annual cash flow from operations?
The current annual CFO of LEGN is -$144.03 M
What is the all time high annual CFO for Legend Biotech?
Legend Biotech all-time high annual cash flow from operations is $307.68 M
What is Legend Biotech annual CFO year-on-year change?
Over the past year, LEGN annual cash flow from operations has changed by +$249.24 M (+63.38%)
What is the all time high quarterly CFO for Legend Biotech?
Legend Biotech all-time high quarterly cash flow from operations is $19.95 M
What is the all time high TTM CFO for Legend Biotech?
Legend Biotech all-time high TTM cash flow from operations is -$4.26 M